|
Medincell is a private drug delivery company committed to the creation and development of long acting parenteral formulations. The corporation, founded in 2002, assists Human and Animal Health companies with MedinGel™, its advanced polymeric drug delivery system. Medincell is leading the field of peptides and proteins delivery.
MedinGel™ drastically improves action durations of peptides and proteins after once subcutaneous administration. The technology thus allows greater patient compliance and convenience thanks to advantageous pharmacokinetic profiles. MedinGel™ also allows regulatory advantages and provides a strong international protection for new chemical entities or off-patent drugs.
Since 2006, MedinCell works with small, middle-size and large pharmaceutical companies convinced that innovation is the key to health improvement.
Welcome to MedinCell !
|
|
|
Our Technologies
MedinGel™, MedinCare™ and MedinHub™ are innovative polymer-based drug delivery systems which provide a powerful tool for human and animal health…… Learn more >
Partnerships
MedinCell is enthusiastically seeking to establish new collaborations and develop innovative solutions… Learn more >
Feasibility studies
Our company has designed an efficient, easy to handle, collaborative procedure, that comprises three technological levels of exploration… Learn more >
Investor Relations
MedinCell is 100% privately owned and has been developed to ensure IPO in 2010. Private or public investors are welcome to join the company’s capital….. Learn more >
|
|
